PHASE I/II TRIAL OF ANTI-HIV ACTIVITY AMP; SAFETY OF MIFEPRISTONE (AACTG 5200)

抗 HIV 活性 AMP 的 I/II 期试验；

• 批准号: 7377563
• 负责人: KRISTINE B. PATTERSON
• 金额: $ 2.21万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2005
• 资助国家: 美国
• 起止时间: 2005-12-01 至 2006-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7377563
• 关键词: PHASE; II; TRIAL; ANTI; HIV

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is being done to evaluate the anti-HIV activity (if the level of HIV in blood can be lowered), and the safety, and tolerability of the drug mifepristone.

该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者（PI）可能从另一个NIH来源获得主要资金，因此可以在其他CRISP条目中表示。所列机构为中心，不一定是研究者所在机构。这项研究正在进行，以评估抗艾滋病毒活性（如果血液中的艾滋病毒水平可以降低），以及药物米非司酮的安全性和耐受性。